BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30784662)

  • 1. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
    Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
    Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
    Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
    von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
    Front Immunol; 2018; 9():3035. PubMed ID: 30619370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
    Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
    Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
    J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy.
    Reinhard L; Thomas C; Machalitza M; Lattwein E; Weiss LS; Vitu J; Wiech T; Stahl RAK; Hoxha E
    Sci Rep; 2021 Aug; 11(1):16188. PubMed ID: 34376704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
    Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
    Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
    J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
    Tian C; Li L; Liu T; Qu X; Qiu Y
    Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
    Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
    N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.
    Matsumoto A; Matsui I; Mano K; Mizuno H; Katsuma Y; Yasuda S; Shimada K; Inoue K; Oki T; Hanai T; Kojima K; Kaneko T; Isaka Y
    BMC Nephrol; 2021 Jul; 22(1):253. PubMed ID: 34229600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Membranous nephropathy: Pathophysiology and natural history].
    Seitz-Polski B; Lambeau G; Esnault V
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers to detect membranous nephropathy in Chinese patients.
    Lin L; Wang WM; Pan XX; Xu J; Gao CN; Zhang W; Ren H; Xie JY; Shen PY; Xu YW; Ni LY; Chen N
    Oncotarget; 2016 Oct; 7(42):67868-67879. PubMed ID: 27634909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study.
    Fouad MA; Mahedy AW; Mansour AE; Fouad NA
    Egypt J Immunol; 2020 Jun; 27(2):1-9. PubMed ID: 33548972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.
    Dettmar AK; Wiech T; Kemper MJ; Soave A; Rink M; Oh J; Stahl RAK; Hoxha E;
    Pediatr Nephrol; 2018 Mar; 33(3):463-472. PubMed ID: 29034405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranous nephropathy: integrating basic science into improved clinical management.
    Cattran DC; Brenchley PE
    Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
    Seitz-Polski B; Payré C; Ambrosetti D; Albano L; Cassuto-Viguier E; Berguignat M; Jeribi A; Thouret MC; Bernard G; Benzaken S; Lambeau G; Esnault VL
    Nephrol Dial Transplant; 2014 Dec; 29(12):2334-42. PubMed ID: 25063424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity.
    Larsen CP; Cossey LN; Beck LH
    Mod Pathol; 2016 Apr; 29(4):421-6. PubMed ID: 26847174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Membranous Nephropathy.
    Couser WG
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):983-997. PubMed ID: 28550082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.